SCR-LIP-000332 · Claim · machine-readable JSON →
This non-systematic review describes lipedema as having a 4-stage clinical classification with documented lymphatic dysfunction (abnormal lymphoscintigraphic patterns, impaired lymphatic transport in early stages, lymphatic aneurysmal structures) and reports impaired functional and cardiovascular parameters, but does not quantify progression rates to lymphedema or measure functional disability outcomes.
Claim at a glance
- Type
- clinical association
- Knowledge state
- Emerging
- Evidence certainty
- very low (GRADE)
- Evidence
- 1 source(s)
- Answers
- 3 question(s)
- Dates
- 2026-05-31 → 2026-05-31
Structured evidence, machine-compiled — not a verdict.
Auto-compiled by the Layer 1 surveillance loop; not yet human-reviewed. anthropic/claude-opus-4.8 · 2026-05-31
Evidence over time
Evidence (1)
- Update in the management of lipedema — FORNER-CORDERO et al. (2021) ✓ verified — contextual · review · 2021 · reading confidence: moderate
“transporte linfático prejudicado em estágios precoces”
The review addresses lymphatic dysfunction and clinical staging relevant to potential progression toward lymphedema, but as a narrative review it provides background/context rather than direct evidence quantifying progression to lymphedema
Context (PECO)
Answers these questions
- Does lipedema progress to lymphedema and cause functional disability? contextual
- Does lipedema progress to lymphedema (lipo-lymphedema)? contextual
- Does lipedema cause functional disability and mobility limitation? contextual
Gaps & caveats
Auto-ingested single source; not yet human-reviewed.
Change log
- 2026-05-31 — created · auto-ingested for SQ-LIP-000017